Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells

American Journal of Reproductive Immunology

Volumn 73, Issue 4, 2015, Pages 330-340

  Knuth, Allison ^a   Liu, Lawrence ^a   Nielsen, Halden ^a   Merril, Daniel ^a   Torry, Donald S ^b   Arroyo, Juan A ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mammalian target of rapamycin; Placenta; Placenta growth factor; Trophoblast invasion

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN P70; RAPAMYCIN; SMALL INTERFERING RNA; MTOR PROTEIN, HUMAN; PLACENTA PROTEIN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; STS-1 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL INVASION; CELL LYSATE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FIRST TRIMESTER PREGNANCY; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TROPHOBLAST; WESTERN BLOTTING; CELL LINE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PREGNANCY; TUMOR INVASION;

CELL LINE; FEMALE; HUMANS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PREGNANCY; PREGNANCY PROTEINS; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; TROPHOBLASTS;

EID: 84924368654     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12327     Document Type: Article

References (36)

1. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A: Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98:648-655.
2. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ: Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999; 106:1019-1022.
3. Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 1997; 99:2152-2164.
4. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116:402-414.
5. Wen Q, Liu LY, Yang T, Alev C, Wu S, Stevenson DK, Sheng G, Butte AJ, Ling XB: Peptidomic identification of serum peptides diagnosing preeclampsia. PLoS ONE 2013; 8:e65571.
6. Arroyo JA, Brown LD, Galan HL: Placental mammalian target of rapamycin and related signaling pathways in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol 2009; 201:616 e611-617.
7. Jeong W, Kim J, Bazer FW, Song G: Stimulatory effect of vascular endothelial growth factor on proliferation and migration of porcine trophectoderm cells and their regulation by the phosphatidylinositol-3-kinase-AKT and mitogen-activated protein kinase cell signaling pathways. Biol Reprod 2014; 90:50.
8. Riverso M, Kortenkamp A, Silva E: Non-tumorigenic epithelial cells secrete MCP-1 and other cytokines that promote cell division in breast cancer cells by activating ERalpha via PI3K/Akt/mTOR signaling. Int J Biochem Cell Biol 2014; 53:281-294.
9. Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, Kumar AP, Fong CW, Tergaonkar V, Hui KM, Sethi G: Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget 2014; V5:1897-1911.
10. Roos S, Jansson N, Palmberg I, Saljo K, Powell TL, Jansson T: Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol 2007; 582:449-459.
11. Volarevic S, Thomas G: Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol 2001; 65:101-127.
12. Busch S, Renaud SJ, Schleussner E, Graham CH, Markert UR: mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res 2009; 315:1724-1733.
13. Wen HY, Abbasi S, Kellems RE, Xia Y: mTOR: a placental growth signaling sensor. Placenta 2005; 26(Suppl A):S63-S69.
14. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z: ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3'-kinase through an extracellular site. Synergistic mitogenic effects of choline phosphate and sphingosine 1-phosphate. J Biol Chem 1997; 272:3064-3072.
15. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T: Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 1999; 274:36843-36851.
16. Iijima Y, Laser M, Shiraishi H, Willey CD, Sundaravadivel B, Xu L, McDermott PJ, Kuppuswamy D: c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells. J Biol Chem 2002; 277:23065-23075.
17. Arroyo JA, Winn VD: Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008; 32:172-177.
18. Park JE, Chen HH, Winer J, Houck KA, Ferrara N: Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269:25646-25654.
19. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003; 9:669-676.
20. Otrock ZK, Makarem JA, Shamseddine AI: Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007; 38:258-268.
21. Tammela T, Enholm B, Alitalo K, Paavonen K: The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65:550-563.
22. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D: Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond) 2007; 112:51-57.
23. Arroyo J, Torry RJ, Torry DS: Deferential regulation of placenta growth factor (PlGF)-mediated signal transduction in human primary term trophoblast and endothelial cells. Placenta 2004; 25:379-386.
24. Bosco C, Buffet C, Diaz E, Rodrigo R, Morales P, Barja P, Terra R, Parra-Cordero M: VEGF in the muscular layer of placental blood vessels: immuno-expression in preeclampsia and intrauterine growth restriction and its association with the antioxidant status. Cardiovasc Hematol Agents Med Chem 2010; 8:87-95.
25. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S: Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J Reprod Immunol 2009; 82:106-111.
26. Meler E, Scazzocchio E, Peguero A, Triunfo S, Gratacos E, Figueras F: Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset. Prenat Diagn 2014; 34:706-710.
27. Odibo AO, Patel KR, Spitalnik A, Odibo L, Huettner P: Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol 2014; 34:186-191.
28. Andraweera PH, Dekker GA, Roberts CT: The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 2012; 18:436-457.
29. Leung DN, Smith SC, To KF, Sahota DS, Baker PN: Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001; 184:1249-1250.
30. Greenberger S, Yuan S, Walsh LA, Boscolo E, Kang KT, Matthews B, Mulliken JB, Bischoff J: Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. J Invest Dermatol 2011; 131:2467-2476.
31. Straszewski-Chavez SL, Abrahams VM, Alvero AB, Aldo PB, Ma Y, Guller S, Romero R, Mor G: The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta 2009; 30:939-948.
32. Groesch KA, Torry RJ, Wilber AC, Abrams R, Bieniarz A, Guilbert LJ, Torry DS: Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast. Placenta 2011; 32:926-931.
33. Chang M, Mukherjea D, Gobble RM, Groesch KA, Torry RJ, Torry DS: Glial cell missing 1 regulates placental growth factor (PGF) gene transcription in human trophoblast. Biol Reprod 2008; 78:841-851.
34. Borras D, Perales-Puchalt A, Ruiz Sacedon N, Perales A: Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction. J Obstet Gynaecol 2014; 34:218-220.
35. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Todros T, Caniggia I: Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008; 93:285-292.
36. Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W, Verlohren S: The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. J Perinat Med 2014; 42:61-68.